U2OS-CRISPR-SNAPf-Nup133 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | U2OS-CRISPR-SNAPf-Nup133 is a genetically engineered human osteosarcoma cell line derived from the parental U2OS background in which the endogenous NUP133 locus has been modified using CRISPR/Cas9-mediated genome editing to encode a C-terminal SNAPf tag. NUP133 is a core component of the Y-complex (NUP107-160 complex), a structural subcomplex essential for nuclear pore complex (NPC) assembly and maintenance. By introducing the SNAPf coding sequence in-frame at the endogenous locus, the fusion protein is expressed under native regulatory control, preserving physiological expression levels and subcellular localization. The SNAPf tag is a fast-labeling variant of the SNAP-tag, an engineered O6-alkylguanine-DNA alkyltransferase that covalently reacts with benzylguanine-conjugated substrates. This enables highly specific and versatile fluorescent labeling of Nup133 in live or fixed cells using cell-permeable or impermeable SNAP substrates. In U2OS-CRISPR-SNAPf-Nup133 cells, the fusion protein localizes to the nuclear envelope in a punctate pattern characteristic of nuclear pore complexes. Because tagging occurs at the endogenous locus, NPC stoichiometry and architecture are minimally perturbed, making this model suitable for quantitative super-resolution microscopy, single-molecule tracking, and kinetic analyses of NPC assembly and turnover. This cell line provides a robust platform for studying nuclear transport, nucleocytoplasmic trafficking dynamics, NPC biogenesis during interphase and post-mitotic nuclear reassembly, and structural organization of the Y-complex within the pore scaffold. The U2OS background offers flat morphology and large nuclei, facilitating high-resolution imaging. U2OS-CRISPR-SNAPf-Nup133 cells are particularly well suited for pulse-chase labeling experiments, correlative light and electron microscopy, and multicolor imaging approaches in combination with additional endogenously tagged nucleoporins or transport factors. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Osteosarcoma |
Characteristics
| Age | 15 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | U2OS-CRISPR-SNAPf-Nup133 (Cytion catalog number 300666) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| Depositor | The Ellenberg Lab (EMBL) |
| GMO Status | GMO-S1: This human osteosarcoma cell line (U2OS-CRISPR-SNAPf-Nup133) contains a CRISPR-introduced SNAPf-Nup133 fusion, enabling fluorescent tagging of the Nup133 nucleoporin. The insert is stably present. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | Nup133, SNAPf-tag |
|---|
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 3.0 g/L Glucose, stable Glutamine, 2.0 mM Sodium pyruvate, 2.2 g/L NaHCO3, 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300666-101225 | Certificate of Analysis | 22. Jan. 2026 | 300666 |